Outlook Therapeutics, Inc. (OTLK)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-05-18) · 99.1 | 8-K (2026-05-13) | ||
| 10-Q | Q1-2026 | 8-K (2026-02-17) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-12-19) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-02-14) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2024-12-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-05-15) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-02-14) · 99.1 | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2023-12-22) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-08-14) · 99.1 | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Stockholders' (deficit) Equity (unaudited) | — |
|
| Consolidated Statements of Stockholders' Deficit | ||
| Consolidated Statements of Stockholders' Equity | — |
|
| Consolidated Statements of Stockholders' Equity (deficit) | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Basis of Presentation and Summary of Significant Accounting Policies | ||
| Collaboration Arrangements | — |
|
| Commitments and Contingencies | ||
| Common Stock and Stockholders' Equity | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Equity Method Investment | ||
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventory | — |
|
| Liquidity | ||
| Organization and Description of Business | ||
| Organization and Operations | — |
|
| Pay Vs Performance Disclosure | ||
| Preferred Stock | — |
|
| Related-party Transactions | ||
| Segment Information | ||
| Stock-based Compensation | ||
| Stockholders' Equity | — |
|
| Subsequent Events | ||